A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

NCT05076552 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Solid Tumor
Solid Tumor

Interventions

DRUG: TACH101

Sponsor

Tachyon Therapeutics, Inc.